Chemotherapy: neurologic complications
Neurologic complications from systemic anticancer therapies impact quality of life and remain an important source of dose-limiting toxicity. These complications may result from the direct toxic effects of the drug on the nervous system or indirectly from metabolic derangements, inflammatory responses, or cerebrovascular disorders induced by the drugs. The neurotoxicities of chemotherapy are widely known, but targeted agents and immunotherapies are also associated with neurologic complications.
Dec. 19, 2020